FDA Approves LUMAKRAS™ (Sotorasib), The First And Only Targeted Treatment For Patients With KRAS G12C-Mutated Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
By: Colorado BioScience Association Date: 06/01/2021
Amgen (NASDAQ: AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved LUMAKRAS™ (sotorasib) for the treatment of adult patients with KRAS G12...
Learn MoreProov Announces New Patented Test Method for Assessing Ovarian Quality
By: Colorado BioScience Association Date: 05/26/2021
– Proov, a science-based hormone testing company and the leader in testing urine for PdG to confirm ovulation, is announcing today that it has received patent issue notification for a utility patent c...
Learn MoreSomaLogic launches the SomaSignal™ Proteomics for Precision Medicine Initiative with healthcare innovators: Emory University, Intermountain Healthcare, CommonSpirit Health and UCHealth
By: Colorado BioScience Association Date: 05/20/2021
SomaLogic announced today its SomaSignal™ Proteomics for Precision Medicine Initiative, the first large-scale, clinically focused partnership effort aimed at equipping healthcare providers with the po...
Learn MoreLightDeck Diagnostics Honored as Bronze Stevie® Award Winner in 2021 American Business Awards® for Its Lab-Quality, 5-Minute Diagnostics Platform
By: Colorado BioScience Association Date: 05/13/2021
LightDeck Diagnostics was named the winner of a Bronze Stevie® Award in the Startup of the Year category in The 19th Annual American Business Awards® today. The company was recognized for it...
Learn MoreKromaTiD receives $2M of growth investment from BroadOak Capital Partners
By: Colorado BioScience Association Date: 05/06/2021
KromaTiD announced BroadOak Capital Partners made a $2M investment in the company. KromaTiD said its sales and operations are rapidly accelerating, driven by growing market adoption of their products...
Learn MoreCerapedics Announces FDA Breakthrough Device Designation Granted for P-15L Bone Graft for the Treatment of Degenerative Disc Disease
By: Colorado BioScience Association Date: 04/29/2021
Cerapedics Inc., an ortho-biologics companydedicated to enhancing the science of bone repair, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device desi...
Learn MoreThe World's First Fully Automated Benchtop Digital Genome Engineering Platform Is Here
By: Colorado BioScience Association Date: 04/28/2021
As synthetic biology continues to grow, advanced benchtop systems are becoming available to make research and product development easier. Now, Inscripta, a digital genome engineering company, has...
Learn MoreAccure Acne, Inc(R) has Launched a Private Placement Offering on the M-Vest Platform to raise up to $20.0 Million
By: Colorado BioScience Association Date: 04/23/2021
Accure Acne, Inc. ("Accure Acne" or the "Company") has launched a private placement offering on the M-Vest platform to raise up to $20.0 million. Accure has developed an energy-based device (the...
Learn MoreCereHealth Corporation Names James Chomas, Ph.D., as New CEO
By: Colorado BioScience Association Date: 04/21/2021
Dr. Chomas brings an added level of industry firepower to CereHealth's accelerated growth and capital investment plans for its innovative brands of medical technology. DENVER, April 20, 2021...
Learn MoreEvergreen Research Hires Geoffrey Uhl as Director of Product Development
By: Colorado BioScience Association Date: 04/19/2021
Evergreen Research, Inc. (Evergreen), leaders in medical device services, today announced Geoffrey (Geoff) Uhl has joined the company as the newest member of the Evergreen executive team. Geoff will o...
Learn More